Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change $ Change
grade A $188.00 0.00% 0.0
BIO.B closed unchanged on Friday, January 13, 2017, on 8 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BIO.B trend table...

Date Alert Name Type % Chg
Jan 13 Calm After Storm Range Contraction 0.00%
Jan 13 Boomer Buy Setup Bullish Swing Setup 0.00%
Jan 13 Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Jan 13 Expansion Breakout Bullish Swing Setup 0.00%
Jan 13 Reversal New Highs Setup Bullish Swing Setup 0.00%
Jan 13 Narrow Range Bar Range Contraction 0.00%
Jan 12 Calm After Storm Range Contraction 0.00%
Jan 12 Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Jan 12 Expansion Breakout Bullish Swing Setup 0.00%
Jan 12 Reversal New Highs Setup Bullish Swing Setup 0.00%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Profile
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 188.0
52 Week Low 124.5
Average Volume 109
200-Day Moving Average 152.92
50-Day Moving Average 172.55
20-Day Moving Average 181.79
10-Day Moving Average 184.61
Average True Range 0.92
ADX 43.23
+DI 101.33
-DI: 25.84
Chandelier Exit (Long, 3 ATRs) 185.24
Chandelier Exit (Short, 3 ATRs) 179.26
Upper Bollinger Band 189.54
Lower Bollinger Band 174.04
Percent B (%b) 0.9
Bandwidth 0.085263